Rocket Pharma CFO resigns; General Counsel named interim CFO

ROCKET PHARMACEUTICALS, INC.

Aaron Ondrey resigned as CFO effective September 5, 2025 to pursue other opportunities.
Martin Wilson, General Counsel and Chief Corporate Officer, appointed interim Principal Financial Officer effective September 8, 2025.
Wilson joined Rocket in November 2021; has nearly 20 years of life sciences legal and executive experience.
No family relationships or transactions with the company beyond compensation for current roles.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.